Latest news with #CRAInternational
Yahoo
03-08-2025
- Business
- Yahoo
CRA International, Inc. (NASDAQ:CRAI) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
CRA International, Inc. (NASDAQ:CRAI) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to US$170 in the week after its latest second-quarter results. CRA International beat revenue expectations by 3.6%, at US$187m. Statutory earnings per share (EPS) came in at US$1.79, some 2.5% short of analyst estimates. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on CRA International after the latest results. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. After the latest results, the three analysts covering CRA International are now predicting revenues of US$733.0m in 2025. If met, this would reflect a satisfactory 2.8% improvement in revenue compared to the last 12 months. Statutory earnings per share are forecast to dip 2.9% to US$8.33 in the same period. In the lead-up to this report, the analysts had been modelling revenues of US$724.3m and earnings per share (EPS) of US$8.44 in 2025. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results. See our latest analysis for CRA International There were no changes to revenue or earnings estimates or the price target of US$236, suggesting that the company has met expectations in its recent result. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values CRA International at US$244 per share, while the most bearish prices it at US$228. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting CRA International is an easy business to forecast or the the analysts are all using similar assumptions. Of course, another way to look at these forecasts is to place them into context against the industry itself. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 5.7% growth on an annualised basis. That is in line with its 7.0% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 5.8% annually. So although CRA International is expected to maintain its revenue growth rate, it's only growing at about the rate of the wider industry. The Bottom Line The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at US$236, with the latest estimates not enough to have an impact on their price targets. With that in mind, we wouldn't be too quick to come to a conclusion on CRA International. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for CRA International going out to 2026, and you can see them free on our platform here.. Even so, be aware that CRA International is showing 2 warning signs in our investment analysis , you should know about... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
02-08-2025
- Business
- Yahoo
CRA International Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
CRA International (NASDAQ:CRAI) Second Quarter 2025 Results Key Financial Results Revenue: US$186.9m (up 9.0% from 2Q 2024). Net income: US$12.1m (up 86% from 2Q 2024). Profit margin: 6.5% (up from 3.8% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$1.81 (up from US$0.95 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period CRA International Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 3.6%. Earnings per share (EPS) missed analyst estimates by 2.5%. Looking ahead, revenue is forecast to grow 4.3% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Professional Services industry in the US. Performance of the American Professional Services industry. The company's shares are down 4.0% from a week ago. Risk Analysis Before you take the next step you should know about the 2 warning signs for CRA International that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
01-06-2025
- Business
- Yahoo
Is Now An Opportune Moment To Examine CRA International, Inc. (NASDAQ:CRAI)?
CRA International, Inc. (NASDAQ:CRAI), might not be a large cap stock, but it saw a decent share price growth of 18% on the NASDAQGS over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. Less-covered, small caps sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let's examine CRA International's valuation and outlook in more detail to determine if there's still a bargain opportunity. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Good news, investors! CRA International is still a bargain right now. According to our valuation, the intrinsic value for the stock is $250.64, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Another thing to keep in mind is that CRA International's share price may be quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again. Check out our latest analysis for CRA International Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to grow by a double-digit 13% in the upcoming year, the short-term outlook is positive for CRA International. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? Since CRAI is currently undervalued, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on CRAI for a while, now might be the time to enter the stock. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy CRAI. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision. If you'd like to know more about CRA International as a business, it's important to be aware of any risks it's facing. You'd be interested to know, that we found 1 warning sign for CRA International and you'll want to know about it. If you are no longer interested in CRA International, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
01-06-2025
- Business
- Yahoo
Is Now An Opportune Moment To Examine CRA International, Inc. (NASDAQ:CRAI)?
CRA International, Inc. (NASDAQ:CRAI), might not be a large cap stock, but it saw a decent share price growth of 18% on the NASDAQGS over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. Less-covered, small caps sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let's examine CRA International's valuation and outlook in more detail to determine if there's still a bargain opportunity. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Good news, investors! CRA International is still a bargain right now. According to our valuation, the intrinsic value for the stock is $250.64, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Another thing to keep in mind is that CRA International's share price may be quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again. Check out our latest analysis for CRA International Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to grow by a double-digit 13% in the upcoming year, the short-term outlook is positive for CRA International. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? Since CRAI is currently undervalued, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on CRAI for a while, now might be the time to enter the stock. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy CRAI. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision. If you'd like to know more about CRA International as a business, it's important to be aware of any risks it's facing. You'd be interested to know, that we found 1 warning sign for CRA International and you'll want to know about it. If you are no longer interested in CRA International, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
27-05-2025
- Business
- Yahoo
Q1 Rundown: FTI Consulting (NYSE:FCN) Vs Other Business Process Outsourcing & Consulting Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the business process outsourcing & consulting stocks, including FTI Consulting (NYSE:FCN) and its peers. The sector stands to benefit from ongoing digital transformation, increasing corporate demand for cost efficiencies, and the growing complexity of regulatory and cybersecurity landscapes. For those that invest wisely, AI and automation capabilities could emerge as competitive advantages, enhancing process efficiencies for the companies themselves as well as their clients. On the flip side, AI could be a headwind as well as the technology could lower the barrier to entry in the space and give rise to more self-service solutions. Additional challenges in the years ahead could include wage inflation for highly skilled consultants and potential regulatory scrutiny on outsourcing practices—especially in industries like finance and healthcare where who has access to certain data matters greatly. The 7 business process outsourcing & consulting stocks we track reported a satisfactory Q1. As a group, revenues were in line with analysts' consensus estimates while next quarter's revenue guidance was 0.5% below. In light of this news, share prices of the companies have held steady as they are up 3.5% on average since the latest earnings results. With a team of experts deployed across 30+ countries to tackle complex business challenges, FTI Consulting (NYSE:FCN) is a global business advisory firm that helps organizations manage change, mitigate risk, and resolve disputes across financial, legal, operational, and regulatory matters. FTI Consulting reported revenues of $898.3 million, down 3.3% year on year. This print fell short of analysts' expectations by 0.9%, but it was still a strong quarter for the company with an impressive beat of analysts' EPS estimates. Steven H. Gunby, President and Chief Executive Officer of FTI Consulting, commented, 'This is a time of disruption for many of our clients; as they assess their risks and opportunities, many of them are finding the depth and breadth of our capabilities across our global platform to be a reason to turn to us.' FTI Consulting delivered the slowest revenue growth of the whole group. The market was likely pricing in the results, and the stock is flat since reporting. It currently trades at $166.75. Is now the time to buy FTI Consulting? Access our full analysis of the earnings results here, it's free. Often retained for high-stakes matters with multibillion-dollar implications, CRA International (NASDAQ:CRAI) provides economic, financial, and management consulting services to corporations, law firms, and government agencies for litigation, regulatory proceedings, and business strategy. CRA reported revenues of $181.9 million, up 5.9% year on year, outperforming analysts' expectations by 3%. The business had a very strong quarter with an impressive beat of analysts' EPS estimates and full-year revenue guidance slightly topping analysts' expectations. CRA delivered the biggest analyst estimates beat and highest full-year guidance raise among its peers. The market seems happy with the results as the stock is up 15.3% since reporting. It currently trades at $185.95. Is now the time to buy CRA? Access our full analysis of the earnings results here, it's free. Originally spun off from General Electric in 2005 to provide business process services, Genpact (NYSE:G) is a global professional services firm that helps businesses transform their operations through digital technology, AI, and data analytics solutions. Genpact reported revenues of $1.21 billion, up 7.4% year on year, in line with analysts' expectations. It was a slower quarter as it posted a slight miss of analysts' EPS guidance estimates. Genpact delivered the weakest full-year guidance update in the group. As expected, the stock is down 12.2% since the results and currently trades at $43.51. Read our full analysis of Genpact's results here. With a team of over 800 consultants holding advanced degrees in 90+ technical disciplines, Exponent (NASDAQ:EXPO) is a science and engineering consulting firm that investigates complex problems and provides expert analysis for clients across various industries. Exponent reported revenues of $137.4 million, flat year on year. This number beat analysts' expectations by 2.1%. However, it was a mixed quarter as it recorded revenue guidance for next quarter slightly missing analysts' expectations. The stock is down 2% since reporting and currently trades at $76.20. Read our full, actionable report on Exponent here, it's free. With over 120 offices across 33 states and a team of more than 6,700 professionals, CBIZ (NYSE:CBZ) provides accounting, tax, benefits, insurance brokerage, and advisory services to help small and mid-sized businesses manage their finances and operations. CBIZ reported revenues of $838 million, up 69.5% year on year. This print came in 2.6% below analysts' expectations. It was a slower quarter as it also logged full-year revenue guidance missing analysts' expectations. CBIZ achieved the fastest revenue growth but had the weakest performance against analyst estimates among its peers. The stock is down 6.9% since reporting and currently trades at $71.93. Read our full, actionable report on CBIZ here, it's free. Thanks to the Fed's series of rate hikes in 2022 and 2023, inflation has cooled significantly from its post-pandemic highs, drawing closer to the 2% goal. This disinflation has occurred without severely impacting economic growth, suggesting the success of a soft landing. The stock market thrived in 2024, spurred by recent rate cuts (0.5% in September and 0.25% in November), and a notable surge followed Donald Trump's presidential election win in November, propelling indices to historic highs. Nonetheless, the outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. The path forward holds both optimism and caution as new policies take shape. Want to invest in winners with rock-solid fundamentals? Check out our Top 6 Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
